Skip to main content
  • Home
  •  Transcatheter Interventions Online - Structural Heart Interventions: Mitral & Tricuspid Live Cases

Transcatheter Interventions Online - Structural Heart Interventions: Mitral & Tricuspid Live Cases

Topic:
  • Intervention
  • Structural Heart Disease

Available Credit:

  • 1.00 EBAC

Course Published On:

Course Expiry Date:

TIO 2020 – Mitral and Tricuspid Live Cases

Overview

In this session, 'Transcatheter Interventions Online 2020 - Structural Heart Interventions: Mitral & Tricuspid Live Cases', procedures at Emory Medical Centre and Leipzip Heart Center demonstrate the latest in mitral and tricuspid treatment strategies, with further insights provided by an international panel.

 

Transcatheter Interventions Online 2020 aims to educate interventionalists and allied healthcare professionals on the practical implications of the latest clinical data, device selection, and procedural strategies impacting optimum patient care. To further illustrate this, the event will feature a number of practical demonstrations in the form of live cases broadcast from cardiovascular centers of excellence globally, interspersed with presentations and debate sessions.

Support Statement

This programme is supported by unrestricted educational grants from the following companies. The scientific programme has not been influenced in any way by the sponsors.

  • Abbott
  • Abiomed
  • Boston Scientific
  • Edwards Lifesciences
  • Medtronic
  • Siemens Healthineers

Disclosure

In compliance with EBAC / EACCME guidelines, all speakers/chairpersons participating in this programme have disclosed or indicated potential conflicts of interest which might cause a bias in the presentations.

 

The Organising Committee/Course Director is responsible for ensuring that all potential conflicts of interest relevant to the event are declared to the audience prior to the CME activities.

    Terms & Conditions

    Radcliffe Education requires contributors to our CME programmes to disclose any relevant financial relationships that have occurred within the past 12 months that could create a conflict of interest. These will be identified in the faculty section if applicable.

     

    This session ‘Transcatheter Interventions Online - Structural Heart Interventions: Mitral & Tricuspid Live Cases’ is accredited by the European Board for Accreditation in Cardiology (EBAC) for 1 hour of external CME credits.

     

    Each participant should claim only those hours of credit that have actually been spent in the educational activity. EBAC works according to the quality standards of the European Accreditation Council for Continuing Medical Education (EACCME), which is an institution of the European Union of Medical Specialists (UEMS).

     

    Through an agreement between the European Board for Accreditation in Cardiology and the American Medical Association, physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™. Information on the process to convert EBAC credit to AMA credit can be found on the AMA website.

    Instructions to Participants

    There is no fee for taking part in this online learning activity.

     

    Activities are designed to be completed within 60 minutes and must be completed by the registered user. Physicians should only claim credits for time spent on the activity. To successfully earn credit, participants must complete the activity in full in the indicated time frame.

     

    To complete the course and claim certification participants must:

    • Read the course outline information supplied and complete pre-test questions if supplied prior to starting the activity. Users must read and study the activity in its entirety before completing the post-test questions.
    • Your results will be automatically saved and if a pass score is achieved (where applicable), you may be eligible to claim credit for the activity and receive a certificate of completion.

    Target Audience

    • Cardiologists
    • Interventionalists
    • Surgeons who are involved and/or interested in transcatheter treatment strategies for coronary and structural heart disease

    Learning Objectives

    Upon completion of this activity, participants will be able to:

    • Evaluate emerging clinical data related to interventional cardiology practice including for both devices and pharmacology
    • Recognise the latest interventional approaches for SHD and Complex PCI available for the optimal management of CV patients
    • Assess the merits of adopting emerging technologies within their practice
    • Apply the practical guidance to maximise success of their interventional procedures within TAVR, Mitral & Tricuspid Valve Replacement and Complex PCIs
    • Interact with opinion leaders in their profession

    Chair

    Ajay J Kirtane

    Columbia University Medical Center and New York-Presbyterian Hospital, New York, NY, US

    Ajay J Kirtane, is Professor of Medicine at the Columbia University Medical Center (CUMC) and Director of the Cardiac Catheterization Laboratories at NewYork-Presbyterian (NYP) Hospital / CUMC. Dr.

    View full profile

    Azeem Latib

    Montefiore Medical Center, New York, NY, US

    Dr Mohamed Azeem Latib is a world-leading expert in Interventional Cardiology. Dr Latib is the Section Head and Director of Interventional Cardiology as well as the Director of Structural Heart Interventions at the Montefiore-Einstein Center for Heart and Vascular Care. 

    View full profile

    Panelist

    Nicolas M Van Mieghem

    Thoraxcenter, Erasmus University Medical Center, Rotterdam, NL

    Prof Nicolas Maria Van Mieghem is an Interventional cardiologist at Thoraxcenter, Erasmus MC, Rotterdam, NL decided to pursue a career that would help others.

    View full profile

    Lars Søndergaard

    Copenhagen University Hospital, Rigshospitalet, Copenhagen, DK

    Professor Lars Søndergaard is a consultant cardiologist at Rigshospitalet – Copenhagen, Denmark. Professor of Cardiology at University of Copenhagen, he published over 300 peer reviewed articles, and more than 15 textbook chapters.

    View full profile

    Kendra J Grubb

    Emory Structural Heart and Valve Center

    Dr Kendra Grubb is the surgical director of the Emory Structural Heart and Valve Center. She is also an associate professor of surgery at Emory University School of Medicine.

    View full profile

    Holger Thiele

    Leipzig Heart Center, Leipzig, DE

    Dr Holger Thiele, former director and full professor in the Department of Internal Medicine/Cardiology/Angiology of the University Heart Center Lübeck at the University of Lübeck has been nominated by the faculty of the University of Leipzig as full Professor and Director of the Department of Int

    View full profile

    Operator

    Adam B Greenbaum

    Cardiac Catheterization Laboratory, Henry Ford Hospital, Detroit, Michigan, US

    View full profile

    Vasilis Babaliaros

    Andreas Gruentzig Cardiovascular Center, Emory University, Georgia

    View full profile

    Philipp Lurz

    Department of Cardiology, University of Leipzig - Heart Center, Leipzig, Germany

    Prof Philipp Lurz is Deputy Head of the Department at Heart Center Leipzig, Germany, a position he has held since 2018. Previously, Prof Lurz was a Clinical Research Fellow at Great Ormond Street Hospital for Children NHS Foundation Trust. He completed his ed

    View full profile

    Thilo Noack

    Heart Centre Leipzig

    View full profile

    Jörg Ender

    Heart Center Leipzig

    View full profile
    1.00 EBAC

    Related Courses

    TIO 2023 – Debates
    • 1.00 EBAC

    Learning objectives

    • Compare the utility of repair and replacement valve technology in mitral regurgitation
    • Individualise valve choice for aortic regurgitation based on valve durability and patient features
    • Recall the utility and limitations of specialty balloons
    • Evaluate emerging approaches to the treatment of complex left main and other coronary bifurcation lesions
    • Discuss the impact of PCI on top of optimal medical therapy in ischaemic left ventricular systolic dysfunction
    • Identify suitable patients for interatrial shunting
    • Discuss the merits of alternative antiplatelet strategies to DAPT in ACS and CCS following PCI
    See more
    TIO 2023 – Debates & Controversies – Live Cases & Discussions
    • 1.00 EBAC

    Learning objectives

    • Compare the utility of repair and replacement valve technology in mitral regurgitation
    • Individualise valve choice for aortic regurgitation based on valve durability and patient features
    • Recall the utility and limitations of specialty balloons
    • Evaluate emerging approaches to the treatment of complex left main and other coronary bifurcation lesions
    • Discuss the impact of PCI on top of optimal medical therapy in ischaemic left ventricular systolic dysfunction
    • Identify suitable patients for interatrial shunting
    See more
    TIO 2023 – Keynote & Debate
    • 1.00 EBAC

    Learning objectives

    • Compare the utility of repair and replacement valve technology in mitral regurgitation
    • Individualise valve choice for aortic regurgitation based on valve durability and patient features
    • Recall the utility and limitations of specialty balloons
    • Evaluate emerging approaches to the treatment of complex left main and other coronary bifurcation lesions
    • Discuss the impact of PCI on top of optimal medical therapy in ischaemic left ventricular systolic dysfunction
    • Identify suitable patients for interatrial shunting
    See more
    TIO 2023 – Left Main & Bifurcations – Live Cases & Discussions
    • 1.00 EBAC

    Learning objectives

    • Compare the utility of repair and replacement valve technology in mitral regurgitation
    • Individualise valve choice for aortic regurgitation based on valve durability and patient features
    • Recall the utility and limitations of specialty balloons
    • Evaluate emerging approaches to the treatment of complex left main and other coronary bifurcation lesions
    • Discuss the impact of PCI on top of optimal medical therapy in ischaemic left ventricular systolic dysfunction
    • Identify suitable patients for interatrial shunting
    • Discuss the merits of alternative antiplatelet strategies to DAPT in ACS and CCS following PCI
    See more
    TIO 2023 – Left Main & Bifurcations
    • 1.00 EBAC

    Learning objectives

    • Compare the utility of repair and replacement valve technology in mitral regurgitation
    • Individualise valve choice for aortic regurgitation based on valve durability and patient features
    • Recall the utility and limitations of specialty balloons
    • Evaluate emerging approaches to the treatment of complex left main and other coronary bifurcation lesions
    • Discuss the impact of PCI on top of optimal medical therapy in ischaemic left ventricular systolic dysfunction
    • Identify suitable patients for interatrial shunting
    • Discuss the merits of alternative antiplatelet strategies to DAPT in ACS and CCS following PCI
    See more
    TIO 2023 – Balloon Revolution – Live Cases & Discussions
    • 1.00 EBAC

    Learning objectives

    • Compare the utility of repair and replacement valve technology in mitral regurgitation
    • Individualise valve choice for aortic regurgitation based on valve durability and patient features
    • Recall the utility and limitations of specialty balloons
    • Evaluate emerging approaches to the treatment of complex left main and other coronary bifurcation lesions
    • Discuss the impact of PCI on top of optimal medical therapy in ischaemic left ventricular systolic dysfunction
    • Identify suitable patients for interatrial shunting
    • Discuss the merits of alternative antiplatelet strategies to DAPT in ACS and CCS following PCI
    See more
    TIO 2023 – Balloon Revolution
    • 1.00 EBAC

    Learning objectives

    • Compare the utility of repair and replacement valve technology in mitral regurgitation
    • Individualise valve choice for aortic regurgitation based on valve durability and patient features
    • Recall the utility and limitations of specialty balloons
    • Evaluate emerging approaches to the treatment of complex left main and other coronary bifurcation lesions
    • Discuss the impact of PCI on top of optimal medical therapy in ischaemic left ventricular systolic dysfunction
    • Identify suitable patients for interatrial shunting
    • Discuss the merits of alternative antiplatelet strategies to DAPT in ACS and CCS following PCI
    See more
    TIO 2023 – Key Issues in TAVI - Live Cases and Discussions
    • 1.00 EBAC

    Learning objectives

    • Compare the utility of repair and replacement valve technology in mitral regurgitation
    • Individualise valve choice for aortic regurgitation based on valve durability and patient features
    • Recall the utility and limitations of specialty balloons
    • Evaluate emerging approaches to the treatment of complex left main and other coronary bifurcation lesions
    • Discuss the impact of PCI on top of optimal medical therapy in ischaemic left ventricular systolic dysfunction
    • Identify suitable patients for interatrial shunting
    • Discuss the merits of alternative antiplatelet strategies to DAPT in ACS and CCS following PCI
    See more
    TIO 2023 – Key Issues in TAVI
    • 1.00 EBAC

    Learning objectives

    • Compare the utility of repair and replacement valve technology in mitral regurgitation
    • Individualise valve choice for aortic regurgitation based on valve durability and patient features
    • Recall the utility and limitations of specialty balloons
    • Evaluate emerging approaches to the treatment of complex left main and other coronary bifurcation lesions
    • Identify suitable patients for interatrial shunting
    • Discuss the merits of alternative antiplatelet strategies to DAPT in ACS and CCS following PCI
    See more
    TIO 2023 – Symposium: Lifetime Patient Management Greater Expectations: Is TAVI Rising to The Challenge?
    • 1.00 EBAC

    Learning objectives

    • Recall the latest data on durability and clinical outcomes for TAVI
    • Understand how TAVI is advancing and become aware of future treatment options for lifetime management of patients with aortic valve disease
    • Become more confident using TAVI in cases with complex anatomy
    See more